Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Warner

Showing results (121-130 of 159) with videos related to

Pageof 16
Sort By:
Journal of Translational Medicine|September 22, 2023
Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesisRamya Ramaswami, Takanobu Tagawa, Guruswamy Mahesh, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2019
Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized TrialRobert Olson, Suresh Senan, Stephen Harrow, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2024
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: Long-Term Clinical OutcomesVivian S Tan, Rohann J M Correa, Timothy K Nguyen, et al.
Journal of Medical Imaging and Radiation Sciences|October 12, 2021
Implementation and evaluation of an online anatomy, radiology and contouring bootcamp for radiation therapistsKrista D'Angelo, Paige Eansor, Leah A D'Souza, et al.
Gynecologic Oncology|March 17, 2018
The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysisX Melody Qu, Vikram M Velker, Eric Leung, et al.
BMC Cancer|July 8, 2022
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trialEdward Yu, Alison L Allan, Michael Sanatani, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2015
Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic ModelAlexander V Louie, Cornelis J A Haasbeek, Sahar Mokhles, et al.
Head & Neck|July 29, 2024
A prospective cohort study on stereotactic radiotherapy in the management of dural recurrence of olfactory neuroblastomaChristopher D Goodman, Franco DeMonte, Theresa P Nguyen, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2022
Functional Lung Avoidance for Individualized Radiation Therapy: Results of a Double-Masked, Randomized Controlled TrialBrian P Yaremko, Dante P I Capaldi, Khadija Sheikh, et al.
Lancet (London, England)|April 16, 2019
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trialDavid A Palma, Robert Olson, Stephen Harrow, et al.
Pageof 16

Showing results (121-130 of 159) with videos related to

Sort By:
Pageof 16
Journal of Translational Medicine|September 22, 2023
Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesisRamya Ramaswami, Takanobu Tagawa, Guruswamy Mahesh, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2019
Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized TrialRobert Olson, Suresh Senan, Stephen Harrow, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2024
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: Long-Term Clinical OutcomesVivian S Tan, Rohann J M Correa, Timothy K Nguyen, et al.
Journal of Medical Imaging and Radiation Sciences|October 12, 2021
Implementation and evaluation of an online anatomy, radiology and contouring bootcamp for radiation therapistsKrista D'Angelo, Paige Eansor, Leah A D'Souza, et al.
Gynecologic Oncology|March 17, 2018
The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysisX Melody Qu, Vikram M Velker, Eric Leung, et al.
BMC Cancer|July 8, 2022
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trialEdward Yu, Alison L Allan, Michael Sanatani, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2015
Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic ModelAlexander V Louie, Cornelis J A Haasbeek, Sahar Mokhles, et al.
Head & Neck|July 29, 2024
A prospective cohort study on stereotactic radiotherapy in the management of dural recurrence of olfactory neuroblastomaChristopher D Goodman, Franco DeMonte, Theresa P Nguyen, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2022
Functional Lung Avoidance for Individualized Radiation Therapy: Results of a Double-Masked, Randomized Controlled TrialBrian P Yaremko, Dante P I Capaldi, Khadija Sheikh, et al.
Lancet (London, England)|April 16, 2019
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trialDavid A Palma, Robert Olson, Stephen Harrow, et al.
Pageof 16